TITLE

New restrictions on celecoxib (Celebrex) use and the withdrawal of valdecoxib (Bextra)

AUTHOR(S)
Cotter, Jill; Wooltorton, Eric
PUB. DATE
May 2005
SOURCE
CMAJ: Canadian Medical Association Journal;5/10/2005, Vol. 172 Issue 10, p1299
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Presents a study which investigated cardiovascular risk associated with celecoxib in a clinical trial for colorectal adenoma prevention. Degree of inhibition of cyclooxygenase 2 relative to cyclooxygenase 1 for various nonsteroidal anti-inflammatory agents; Advice on the use of celecoxib.
ACCESSION #
16900688

 

Related Articles

  • Renal effects of cyclooxygenase inhibitors in volume-depleted dogs. Brooks, David P.; Adams, Jerry; DePalma, P. Dennis; Webb, Edward F.; Palmer, Robert H.; Griswold, Don E. // Inflammopharmacology;2000, Vol. 8 Issue 1, p69 

    Objective: The objective of this study was to investigate the renal effects of celecoxib, a cyclooxygenase-2 (COX-2) specific nonsteroidal anti-inflammatory drug (NSAID). Subjects and treatment: Six volume-depleted, conscious, chronically instrumented dogs received four treatments using a...

  • Celecoxib and rofecoxib. Moore, Paul A.; Hersh, Elliot V. // Journal of the American Dental Association (JADA);Apr2001, Vol. 132 Issue 4, p451 

    Reports on the development of the nonsteroidal anti-inflammatory drugs (NSAID), celecoxib and rofecoxib, to limit the adverse effects seen after chronic use of NSAID. Cyclo-oxygenase mechanism; Specific cyclo-oxygenase 2 inhibitors; Decrease in the antihypertensive effects of...

  • Celecoxib. O'Rourke, Maureen E. // Clinical Journal of Oncology Nursing;May/Jun2000, Vol. 4 Issue 3, p143 

    Provides information on Celecoxib, a nonsteroidal anti-inflammatory drug and a cyclooxygenase-2-inhibitor. Indications of the drug; Effect of the drug on blood count; Precautions for the drug.

  • Coxib medications to be handled with care. Misak, Aleksandra // CMAJ: Canadian Medical Association Journal;2/1/2005, Vol. 172 Issue 3, p330 

    Discusses the health risks of coxib medications or the cyclooxygenase-2 (COX-2) inhibitors. Increase in the risk of myocardial infarction and cerebrovascular accident in patients taking celecoxib; Indication of COX-2 inhibitors; Logic of using COX-2 inhibitors as a replacement for nonsteroidal...

  • COX-2 inhibitor drugs. Peters, Michael // BMA A-Z Family Medical Encyclopedia;2004, p201 

    An encyclopedia entry for "COX-2 inhibitor drugs" is presented. They refer to a group of nonsteroidal anti-inflammatory drugs (NSAIDs) which are less likely to cause stomach irritation. Celecoxib is one example of a COX-2 inhibitor drug.

  • COX-2 controversy: where are we and where do we go from here? Khanna, Dinesh; Khanna, Puja P.; Furst, Daniel E. // Inflammopharmacology;2005, Vol. 13 Issue 4, p395 

    Much has been written in the last few months on the association between the cyclooxygenase-2 (COX-2)-selective inhibitors and cardiovascular events. We summarize the randomized controlled studies of different COX-2 inhibitors that led to rofecoxib withdrawal, provide evidence on the differences...

  • Introduction � The coxib controversies. Rainsford, K. D. // Inflammopharmacology;2005, Vol. 13 Issue 4, p331 

    Much concern has arisen in the past year concerning the occurrence of serious cardiovascular adverse reactions from rofecoxib, celecoxib and some other members of the coxib group of NSAIDs. Factors underlying the sudden appearance of these events have been proposed to include the use of high...

  • COX-2 Inhibitors Celecoxib and Parecoxib: Valuable Options for Postoperative Pain Management. Gajraj, Noor M. // Current Topics in Medicinal Chemistry;Feb2007, Vol. 7 Issue 3, p235 

    COX-2 inhibitors are equally as efficacious as the non-selective NSAIDs for the treatment of postoperative pain, but have the advantages of a better gastrointestinal side-effect profile as well as a lack of antiplatelet effects. There have been recent concerns regarding the cardiovascular side...

  • Prescribing COX-2 inhibitors. Newson, Louise // GP: General Practitioner;12/8/2006, p42 

    The article presents information on clinical trials examining the association of COX-2 inhibitors with the cardiovascular events. One of the trials has suggested that celecoxib is associated with an excess of cardiovascular events. Another trial has indicated that COX-2 inhibitors and high-dose...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics